Ag-tech startup Athian secures investors for $5M funding round
Athian expects to begin beta testing for its first product this month. The company was launched last year by Greenfield-based Elanco and Indianapolis-based High Alpha Innovation.
Elanco
-
Pandemic pet adoptions propel rise of $500 billion global market
A wave of adoptions during the COVID-19 pandemic has created greater demand for basics like food and toys, as well as sophisticated medical care that can prolong a pet’s life.
Read More -
Elanco’s shares slip to all-time low after Moody’s downgrade
Moody’s action pushed Elanco’s credit rating further into “junk bond” territory, an area considered riskier than investment-grade debt.
Read More -
Investors wary as Elanco pins hopes on new products
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
Read More -
Elanco shares fall 12% on disappointing revenue outlook
The Greenfield-based maker of animal medicines said fourth-quarter revenue fell due to “environmental and competitive pressure” and could continue to slip this year.
Read More
Articles
Editorial: Let’s meet Elanco CEO’s challenge
Elanco Animal Health CEO Jeff Simmons says Indianapolis faces “significant realities” it must tackle to become a destination for talent, companies and innovators.
Elanco CEO says ‘another level of urgency’ needed to improve downtown
Speaking during a luncheon hosted by the Economic Club of Indiana on Wednesday, Elanco CEO Jeff Simmons addressed downtown’s struggles with homelessness, infrastructure, talent attraction and retention, and real estate.
Going strong: U.S. dollar gained value against key currencies in past year
When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
Elanco’s new HQ project nearing city approval, with a few issues outstanding
The Greenfield-based company will lay out the design for its $100 million-plus global headquarters in Indianapolis on Thursday before a hearing examiner, who will rule on the project.
Federal judge dismisses investors’ complaint against Elanco alleging ‘channel stuffing’
U.S. District Court Judge Sarah Evans Barker ruled the plaintiffs failed to clearly show that public statements made by Elanco’s top officials were false and misleading during a two-year period in question.
Elanco spinoff BiomEdit locates HQ in Fishers
BiomEdit, one of Indiana’s newest life-science companies, said Monday it will locate its headquarters in Fishers, but hinted it could eventually move to the new $100 million Elanco Animal Health headquarters campus now under construction in Indianapolis.
Elanco reports solid quarter but global concerns lead to drop in share price
Several analysts said Elanco faces a bright future, implying that the market might be overreacting to the lowered revenue and profit guidance.
IBJ Podcast: Jeff Simmons on Elanco’s global HQ and creating a magnet for talent, innovation
CEO Jeff Simmons explains why the project is far more than simply an office building. He tells host Mason King that the goal is to create what the company calls “a post-COVID workplace destination” that attracts talent to the city and the company and gives workers more flexibility and engagement.
Nate Feltman: Elanco planned HQ campus is promising for downtown growth
CEO Jeff Simmons’ goal is to make Indianapolis “an epicenter of animal health innovation.” While a bold goal, Simmons has proven he is a bold leader who prioritizes the growth of his company, as well as the community.
Elanco unveils plans for new ‘epicenter of animal health innovation’
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.
Elanco’s financial picture strengthens as company prepares for HQ groundbreaking
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
Elanco, High Alpha Innovation launch ag-tech startup Athian
The startup, Athian, aims to help farmers and ranchers measure, and eventually monetize, their efforts to reduce the carbon footprint of their cattle operations.
Elanco eyes early 2022 groundbreaking for stamping plant HQ project
Elanco Animal Health Inc. officials say they expect to break ground on the company’s new $100 million headquarters just west of downtown Indianapolis in early 2022 after fine-tuning plans for the project with city and state officials.
Elanco cuts 380 positions, including about 20% of senior management
Elanco said the cuts, which include three executive vice presidents, were an effort in “streamlining and simplifying organizational structure,” and were intended to increase productivity and reduce organizational complexity.
SEC subpoenas Elanco records related to sales practices
Greenfield-based Elanco Animal Health Inc. disclosed on Monday that it received a subpoena from the U.S. Securities and Exchange Commission on July 1 related to its channel inventory and sales practices prior to mid-2020.
Elanco shares plunge 15% after mixed full-year outlook
Shares of the Greenfield-based maker of animal feeds and vaccines dove after the firm warned that it’s facing inflationary pressures, increased logistics costs and other headwinds.
Elanco’s $100M headquarters gets final funding approval from city
The project was given a final, and unanimous, approval by the city’s Metropolitan Development Commission—the last step necessary to allow the city to request the funds from the Indianapolis Bond Bank.
Council approves $135M in tax-increment financing bonds for Elanco project
The tax-increment financing bonds will be used to pave the way for Elanco Animal Health Inc. to build its new headquarters on the former General Motors stamping plant property west of downtown.
Elanco to buy California pet med company for $440M
The deal would boost Greenfield-based Elanco’s profile in the billion-dollar pet dermatology market and continue its acquisition strategy.